Studies on the dermal and systemic bioavailability of polycyclic aromatic compounds in high viscosity oil products

Archives of Toxicology

Volumn 73, Issue 3, 1999, Pages 129-140

  Potter, David ^b   Booth, Ewan D ^a   Brandt, Henk C A ^a,d   Loose, Robert W ^a   Priston, Robert A J ^c   Wright, Alan S ^b   Watson, William P ^a  

^a SHELL RESEARCH AND TECHNOLOGY CENTRE   (Netherlands)

^b Shell Research Ltd   (United Kingdom)

^c Shell Chemicals Ltd   (United Kingdom)

^d Oil Prod Hlth/Environ Consultant   (Netherlands)

Author keywords

Benzo(a)pyrene; Bioavailability; Bitumen; Mineral oil; Skin

Indexed keywords

ASPHALT; BENZO[A]PYRENE; MINERAL OIL; POLYCYCLIC AROMATIC COMPOUND;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOAVAILABILITY; BLOOD LEVEL; CONCENTRATION (PARAMETERS); ENVIRONMENTAL EXPOSURE; ENZYME ACTIVITY; FEMALE; GENOTOXICITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIOACTIVITY; SKIN ABSORPTION; SKIN PENETRATION; VISCOSITY;

ANIMALS; BENZO(A)PYRENE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DNA; FEMALE; HUMANS; MICE; MINERAL OIL; POLYCYCLIC HYDROCARBONS, AROMATIC; SKIN ABSORPTION; SPECIFIC PATHOGEN-FREE ORGANISMS; VISCOSITY;

ANIMALIA;

EID: 0033037124     PISSN: 03405761     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002040050597     Document Type: Article

References (26)

1. Ames BN (1979) Identifying environmental chemicals causing mutations and cancer. Science 204: 587-593
2. Blackburn GR, Deitch RA, Schreiner CA, Mehlman MA, Mackerer CR (1984) Estimation of the dermal carcinogenic activity of petroleum fractions using a modified Ames assay. Cell Biol Toxicol 1: 40-48
3. Blackburn GR, Deitch RA, Schreiner CA, Mackerer CR (1986) Predicting carcinogenicity of petroleum distillation fractions using a modified Salmonella mutagenicity assay. Cell Biol Toxicol 2: 63-84
4. 32P-postlabelling-detection of DNA adducts in mouse skin in vivo with the polycyclic aromatic compound content and mutagenicity in Salmonella typhimurium of a range of oil products. Arch Toxicol 72: 505-513
5. Brandt HCA, Booth ED, de Groot PC, Watson WP (1999) Development of a carcinogenic potency index for dermal exposure to viscous oil products. Arch Toxicol 73: 180-188
6. CONCAWE (1990) Factors affecting the skin penetration and carcinogenic potency of petroleum products containing polycyclic aromatic compounds. Report no. 90/55, Conservation of Clean Air and Water in Europe (CONCAWE), Brussells
7. CONCAWE (1994) The use of the dimethyl sulphoxide (DMSO) extract by the IP 346 method as an indicator of the carcinogenicty of lubricant base oils and distillate aromatic extracts. Report no. 94/51, Conservation of Clean Air and Water in Europe (CONCAWE), Brussells
8. Ehrenberg L, Osterman-Golkar S (1980) Alkylation of macromolecules for detecting mutagenic agents. Teratog Mutag Carcinogen 1: 105-127
9. Guerin MR (1978) Energy sources of polycyclic aromatic hydrocarbons. In: Gelboin HV, Ts'O POP (eds) Polycyclic hydrocarbons and cancer, vol 1. Academic Press, New York, pp 3-42
10. Huckle KR, Smith RJ, Watson WP, Wright AS (1986) Comparison of hydrocarbon - DNA adducts formed in mouse skin in vivo and in organ culture in vitro following treatment with benzo(a)pyrene. Carcinogenesis 7: 965-970
11. Ingram AJ, Phillips JC (1993) The dermal bioavailability of radiolabelled benzo[a]pyrene from acetone or from oils of differing viscosity, assessed by DNA and protein binding. J Appl Toxicol 13: 25-32
12. IARC (1984) Polynuclear aromatic hydrocarbons. Part 2. Carbon blacks, mineral oils (lubricant base oils and derived products) and some nitroarenes. IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans, vol 33, International Agency for Research on Cancer, Lyon, France, pp 87-168
13. IARC (1987) Polynuclear aromatic hydrocarbons. Overall evaluations of carcinogenicity: an updating of IARC Monographs 1 to 42. IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans, suppl 7. International Agency for Research on Cancer, Lyon, France, pp 252-253
14. Institute of Petroleum (1993) Determination of polycyclic aromatics in unused lubricating base oils and asphaltene free petroleum fractions - DMSO refractive index method. IP346/92, Standard methods for analysis and testing and related products, vol 2. Wiley, Chichester
15. Lijinsky W (1991) The formation and occurrence of polynuclear aromatic hydrocarbons associated with food. Mutat Res 259: 251-262
16. McKee RH, Daughtrey WC, Freeman JJ, Federici TM, Phillips RD, Plutnick RT (1989) The dermal carcinogenic potential of unrefined and hydrotreated lubricating oils. J Appl Toxicol 9: 265-270
17. Miller EC, Miller JA (1981) Searches for ultimate carcinogens and their reactions with cellular macromolecules. Cancer 47: 2327-2345
18. Osterman-Golkar S, Ehrenberg L, Segerbäck D, Hällström I (1976) Evaluation of genetic risks of alkylating agents. II. Haemoglobin as a dose monitor. Mutat Res 34: 1-10
19. 14C] ethylene oxide. Arch Toxicol Suppl 13: 254-257
20. Potter D, Clarius T, Wright AS, Watson WP (1994) Molecular dosimetry of DNA adducts in rainbow trout (Oncorhynchus mykiss) exposed to benzo(a)pyrene by different routes. Arch Toxicol 69: 1-7
21. 32P-labelling test for DNA damage. Proc Natl Acad Sci USA 78: 6126-6129
22. Watson WP (1987) Post-radiolabelling for detecting DNA damage. Mutagenesis 2: 319-331
23. Watson WP, van Sittert NJ (1995) Molecular approaches to assess cancer risks. Process Safety Environ Protect, Trans Inst Chem Eng B 73: S28-S31
24. Watson WP, Smith RJ, Huckle KR, Wright AS (1989) Use of organ cultures in human risk assessment: comparisons of benzo(a)pyrene-DNA adducts in mouse and human skin. Toxicol In Vitro 3: 60-79
25. 14C] vinyl chloride. In: Garner RC, Farmer PB, Steel GT, Wright AS (eds) Human carcinogen exposure; biomonitoring and risk assessment. Oxford University Press, pp 421-428
26. Wright AS, Watson WP (1991) The direct determination of human carcinogens and assessment of low level risks. In: Groopman JD and Skipper PL (eds) Molecular dosimetry and human cancer: analytical, epidemiological and social considerations. CRC Press, Boca Raton, Florida, USA, pp 3-14